Hepatitis C virus (HCV) infection is highly prevalent and is associated with substantial morbidity and mortality among persons infected with the human immunodeficiency virus (HIV). We compared the ...

Chronic hepatitis C virus (HCV) infection is a cause of major complications in persons who are also infected with the human immunodeficiency virus (HIV). However, the treatment of HCV infection in ...

March 30, 2012 (New York, New York) — Peginterferon alfa-2a, in combination with the protease inhibitor boceprevir and ribavirin (R), was shown to have efficacy equivalent or superior to that seen ...

The combination of bulevirtide plus peginterferon alfa-2a is superior to bulevirtide monotherapy for achieving undetectable hepatitis D virus (HDV) RNA level at 24 weeks after the end of treatment in ...

Efficacy and tolerability were similar between regimens. Hepatitis C virus (HCV) infection is treated with peginterferon in combination with ribavirin. Two main types of peginterferon-based regimens ...

Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive Patients PEG-IFNα-2a was administered ...

Weekly peginterferon alfa-2a therapy, with or without daily adefovir, cleared hepatitis D virus (HDV) RNA in about one quarter of patients who participated in the Hep-Net-International Delta Hepatitis ...

An audit could be carried out to ensure that adefovir dipivoxil and peginterferon alfa-2a are being used appropriately for the treatment of people with chronic hepatitis B. An audit could be carried ...